Nivolumab for hepatocellular carcinoma (HCC) in a real-world context.

被引：5
|
作者：
Rao, Nisha
Rizk, Emanuelle M.
Hwang, Regina
Gartrell, Robyn Denise
Makkar, Jasnit
Oza, Jay
Najjar, Marc
Emond, Jean
Fox, Alyson
Verna, Elizabeth
Brejt, Sidney
Reis, Stephen
Sheynzon, Vladimir
Sperling, David
Weintraub, Joshua
Saenger, Yvonne M.
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Columbia Univ, Irving Med Ctr, New York, NY USA
[3] Columbia Univ, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15675
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15675
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
    Chen, Yen-Hao
    Tsai, Ching-Hua
    Chen, Yen-Yang
    Wang, Chih-Chi
    Wang, Jing-Houng
    Hung, Chao-Hung
    Kuo, Yuan-Hung
    BMC CANCER, 2023, 23 (01)
  • [2] Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
    Yen-Hao Chen
    Ching-Hua Tsai
    Yen-Yang Chen
    Chih-Chi Wang
    Jing-Houng Wang
    Chao-Hung Hung
    Yuan-Hung Kuo
    BMC Cancer, 23
  • [3] Real-world data on nivolumab treatment in Asian patients with advanced hepatocellular carcinoma
    Yoon, S. E.
    Hur, J. Y.
    Lee, K. K.
    Lee, S. J.
    Lee, J.
    Paik, S. W.
    Lim, H. Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With Nivolumab
    Lee, Shou-Wu
    Yang, Sheng-Shun
    Lee, Teng-Yu
    GASTROENTEROLOGY RESEARCH, 2024, 17 (01) : 15 - 22
  • [5] Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
    Kuo, Hsin-Yu
    Han, Meng-Zhi
    Liao, Chih-Hsiang
    Lin, Yih-Jyh
    Wang, Chung-Teng
    Chen, Shang-Hung
    Chang, Ting-Tsung
    Chen, Po-Jun
    Lin, Sheng-Hsiang
    Chen, Chiung-Yu
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Wu, Juei-Seng
    Hong, Tzu-Chun
    Hsieh, Ming-Tsung
    Lee, Yang-Cheng
    Wu, Hung-Tsung
    Tsai, Hong-Ming
    PHARMACEUTICS, 2022, 14 (11)
  • [6] Real-world experience and outcomes of hepatocellular carcinoma (HCC) treated with transarterial radioembolization (TARE)
    Das, Parthib
    Min, Eric
    Paul, Samuel
    Manne, Ashish
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 463 - 463
  • [7] Real-world evidence in hepatocellular carcinoma
    Mospan, Andrea R.
    Morris, Heather L.
    Fried, Michael W.
    LIVER INTERNATIONAL, 2021, 41 : 61 - 67
  • [8] Regorafenib versus nivolumab after sorafenib failure: real-world data in patients with hepatocellular carcinoma
    Choi, Won-Mook
    Choi, Jonggi
    Shim, Ju Hyun
    Lim, Young-Suk
    Lee, Han Chu
    Kim, Kang Mo
    JOURNAL OF HEPATOLOGY, 2020, 73 : S39 - S39
  • [9] Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience
    Hsu, Wei-Fan
    Chuang, Po-Heng
    Chen, Cheng-Kuo
    Wang, Hung-Wei
    Tsai, Ming-Hung
    Su, Wen-Pang
    Chen, Hung-Yao
    Yang, Chi-Ying
    Lin, Chun-Che
    Huang, Guan-Tarn
    Lin, Jaw-Town
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (12): : 4547 - +
  • [10] Real-world data of nivolumab in advanced hepatocellular carcinoma: A multi-centric and retrospective study
    Sardinha, M.
    Simao, D.
    Reis, A.
    Spencer, A.
    Parmanande, A.
    Saraiva, R.
    Calinas, F.
    Filipe, F.
    Winckler, P.
    da Luz, R.
    Martins, M.
    Gramaca, J.
    Ramos, M.
    Cadavez, E.
    Moura, M.
    Gil, L.
    Presa, J.
    Carrola, P.
    Pinho, I.
    Carvalho, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S127 - S127
12345